Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 06-2024 | 12-2023 | 06-2023 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,682 | N/A | -29,317 | -14,649 | -22,661 |
| Depreciation Amortization | 1,395 | N/A | 183 | 3,285 | 60 |
| Other Working Capital | 3,287 | N/A | 487 | -2,194 | -55 |
| Other Operating Activity | 2,273 | 0 | 16,697 | 1,693 | 2,264 |
| Operating Cash Flow | $-14,728 | $N/A | $-11,951 | $-11,865 | $-20,392 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | N/A | -1,297 | -232 | N/A |
| Net Acquisitions | -5,995 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6,052 | $N/A | $-1,297 | $-232 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,568 | N/A | 2,685 | N/A | N/A |
| Common Stock Issued | 7,049 | N/A | N/A | 1,903 | 21,643 |
| Common Stock Repurchased | N/A | N/A | -25 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -8 | -8 |
| Other Financing Activity | -5,844 | 0 | 0 | -43 | 0 |
| Financing Cash Flow | $29,773 | $N/A | $2,660 | $1,852 | $21,635 |
| Beginning Cash Position | 3,665 | N/A | 14,253 | 11,780 | 10,537 |
| End Cash Position | 12,657 | N/A | 3,665 | 1,535 | 11,780 |
| Net Cash Flow | $8,992 | $N/A | $-10,588 | $-10,245 | $1,243 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,728 | N/A | -11,951 | -11,865 | -20,392 |
| Capital Expenditure | -58 | N/A | -1,297 | -232 | 0 |
| Free Cash Flow | -14,786 | 0 | -13,248 | -12,097 | -20,392 |